NGNE – neurogene inc. (US:NASDAQ)
Stock Stats
News
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Neurogene Inc. (NGNE) and Encourages Investors to Learn More About the Investigation
Neurogene Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Neurogene Inc. (NGNE)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE
Neurogene Inc. (NGNE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Neurogene Inc. (NASDAQ: NGNE) had its price target lowered by analysts at BMO Capital Markets from $60.00 to $45.00. They now have an "outperform" rating on the stock.
Form 8-K Neurogene Inc. For: Nov 20
Form 10-Q Neurogene Inc. For: Sep 30
Form 8-K Neurogene Inc. For: Nov 18
Form 8-K Neurogene Inc. For: Nov 18
Form SC 13G/A Neurogene Inc. Filed by: GREAT POINT PARTNERS LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.